The largest database of trusted experimental protocols

6 protocols using nocodazole

1

Characterization of Neisseria gonorrhoeae antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purified chicken IgY anti-Neisseria gonorrhoeae antibody was raised against formalin-killed FA1090 gonococci by Cocalico Biologicals and it cross-reacts with the MS-11, FA19 and F62 strains. The rabbit anti-N.g polyclonal antibody (cat# 20-NR08) was purchased from Fitzgerald Industries. Rabbit monoclonal antibodies against the following antigens were purchased from Cell Signaling—Rab5 (C8B1), Rab7 (D95F2), EEA1 (C45B10), GM130 (D6B1), Ezrin (#3145), LC3A/B (D3U4C), V5-Tag (E9H80), CEACAM1 (D3R80) and ACTR2 (#3128S). Mouse antibodies against the following antigens were purchased from Santa Cruz–Actin (sc8432), FMNL1 (sc390466), FMNL2 (sc390298), FHOD1 (sc365473), DAAM1 (sc100942). Mouse anti-Cas9 (7A9-3A3) was purchased from Cell Signaling. Anti-FMNL3 (ab57963) and anti-Galectin 3 (ab2785) mouse monoclonal antibodies were purchased from Abcam. Anti-human LAMP-2 (H4B4) was purchased from BioLegend. Anti-DIAPH2 (A300-079A-T) was purchased from Bethyl Labs. Highly cross-absorbed Alexa fluorophore conjugated secondary antibodies were purchased from Life Technologies.
Inhibitors used in this study were purchased from: (1) Cayman Chemicals—cytochalasin D (5μM), CK869 (10μM), Dynasore (30μM), GSK269962 (1μM), Nocodazole (3μM), ML-141 (5μM), EHT 1864 (5μM), BMS-5 (1μM) and (-) blebbistatin (5μM); (2) Cell Signaling—LY294002 (10μM); (3) Abcam—SMIFH2 (12.5μM to 100μM).
+ Open protocol
+ Expand
2

Cell Cycle Synchronization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were synchronized in G1/S phase by double thymidine block as previously described (Moudgil et al., 2015) [43 (link)]. Cells were treated with 2 mM thymidine for 16 h with an 8 h release interval between thymidine treatments. Cell synchronization in prometaphase was performed 8 h post release from thymidine treatment by the addition of 200 ng/mL of nocodazole (Cell Signalling; 2190S) for 4 h. Cell synchronization described in Figures 57 (measuring NEBD to anaphase), cells were released from 2nd thymidine block for 9 h and then subjected to indicated treatments. Cell synchronization in metaphase was achieved using 25 µM MG-132 (Sigma-Aldrich; M7449).
+ Open protocol
+ Expand
3

Cytoskeleton Modulation in Cellular Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitors were added in fresh growth medium 30 min prior to injury. DMSO (Fisher Scientific #BP231) was added at 0.2% (v/v) as a vehicle control. Blebbistatin (Cayman Chemical #24171) was used at 100 μM. Myosin light chain kinase inhibitory peptide 18 (P18, Cayman Chemical #19181) was used at 10 μM. ROCK inhibitor Y27632 (Cayman Chemical #10005583) was used at 10 μM. Nocodazole (Cell Signaling #2190s) was used at 100 nM. Dynasore (Sigma #D7693) was used at 60 μM. Latrunculin A (Sigma #428026) was used at 1 μM.
+ Open protocol
+ Expand
4

Cell Cycle Inhibitors Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitors used in this study with their concentrations were as follows: Palblociclib (100 nM, Med Chem Express, HY-50767), CDK1i (10 μM, Sigma-aldrich, SML0569), pro-TAME (15 mM, R&D systems, I44001 M), APCin (30 μM, R&D systems, I44405 M). Nocodazole (0.1 μg/ml, Cell Signaling Technology #2190).
+ Open protocol
+ Expand
5

Antibodies and Inhibitors for Gonococcal Trafficking

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purified chicken IgY anti-Neisseria gonorrhoeae antibody was raised against formalin-killed FA1090 gonococci by Cocalico Biologicals and it cross-reacts with the MS-11, FA19 and F62 strains. The rabbit anti-N.g polyclonal antibody (cat# 20-NR08) was purchased from Fitzgerald Industries. Rabbit monoclonal antibodies against the following antigens were purchased from Cell Signaling -Rab5 (C8B1), Rab7 (D95F2), EEA1 (C45B10), GM130 (D6B1), Ezrin (#3145), LC3A/B (D3U4C), V5-Tag (E9H80), CEACAM1 (D3R80) and ACTR2 (#3128S).
Mouse antibodies against the following antigens were purchased from Santa Cruz -Actin (sc8432), FMNL1 (sc390466), FMNL2 (sc390298), FHOD1 (sc365473), DAAM1 (sc100942).
Mouse anti-Cas9 (7A9-3A3) was purchased from Cell Signaling. Anti-FMNL3 (ab57963) and anti-Galectin 3 (ab2785) mouse monoclonal antibodies were purchased from Abcam. Anti-human LAMP-2 (H4B4) was purchased from BioLegend. Anti-DIAPH2 (A300-079A-T) was purchased from Bethyl Labs. Highly cross-absorbed Alexa fluorophore conjugated secondary antibodies were purchased from Life Technologies.
Inhibitors used in this study were purchased from: (1) Cayman Chemicals -cytochalasin D (5µM), CK869 (10µM), Dynasore (30µM), GSK269962 (1µM), Nocodazole (3µM), ML-141 (5µM), EHT 1864 (5µM), BMS-5 (1µM) and (-) blebbistatin (5µM); (2) Cell Signaling -LY294002 (10µM); (3) Abcam -SMIFH2 (25µM).
+ Open protocol
+ Expand
6

Cytoskeleton Dynamics in Hypo-osmotic Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vimentin-EGFP, vimentin-mCherry, nestin-GFP, and tubulin-GFP were kind gifts from John Eriksson (Turku, Finland). The hypo-osmotic medium was made by using complete growth medium diluted appropriately in deionized water (dilution 1:9 to obtain 30 mOsm, 1:4 to obtain 60 mOsm, and 1:1 to obtain 150 mOsm) and used in all the experiments except Figure S1C. Alternatively, dialyzed serum was added into diluted DMEM with deionized water in Figure S1C which was used to verify the phenotype. Microtubule assembly was inhibited by 10 μM nocodazole for 1.5 hours (#2190S, Cell Signaling, Danvers, MA). Dynein was inhibited by 20 μM ciliobrevin D for 45 minutes (#M60041; Xcessbio, San Diego, CA) under serum deprivation to facilitate its efficient inhibition. Actin assembly was inhibited by 5 μg/mL cytochalasin D for 1 hour (#PHZ1063; Thermo Fisher Scientific, Waltham, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!